Novus Acquisition & Development Corp. (NDEV) Stock Price & Analysis
Novus Acquisition & Development Corp. (NDEV) — price $0.0131 (0.00%), as of the Oct 5, 2026 trading session; market cap $1.39M.
Educational signal · not a buy or sell recommendation · How to read this
Novus Acquisition & Development Corp. · NDEV
Novus Acquisition & Development Corp. operates as an insurance company, focusing on health policies within the cannabis space. The company offers a range of benefit plans and THC health plans in California.
Price as of Oct 5, 2026
Key Statistics
Not scored: this is a debt/preferred or other non-common instrument, or its reported market value does not match its share basis.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $0.0131 | |
| Change on the day | 0.00% | |
| 52-week range | $0.0028 – $0.0327 | |
| Market capitalisation | $1.39M | |
| Price / earnings (trailing) | 11.91 | |
| Shares traded on the day | 625 |
Price & events
Watch the NDEV film — every key number, told as a short cinematic story
~2 min · open the film
What is Novus Acquisition & Development (NDEV), and what does it report?
Short answer · as of
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Novus Acquisition & Development Corp. (NDEV) is the company analyzed here. It employs 1 people and is led by Gary Frank Labrozzi. In Q2 FY2026 it reported revenue of $107,785 and net income of $50,838. The market values it at $1.39M.
What do the latest results show for Novus Acquisition & Development (NDEV)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of $107,785.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | $107,785 | $50,838 | $0.00 (diluted) |
| Q1 FY2026 | $106,613 | $47,755 | $0.0004 (diluted) |
| Q4 FY2025 | $104,844 | $42,664 | $0.0003 (diluted) |
| Q3 FY2025 | $102,347 | $55,233 | $0.0004 (diluted) |
What are the financial strengths and risks for Novus Acquisition & Development (NDEV)?
Short answer
The distress and quality screens read Altman Z 0.56 · Piotroski F 4. Trailing ratios: ROE 10.4% · ROA 10.0% · current ratio 1.43 · earnings yield 9.8%.
What has been published about Novus Acquisition & Development (NDEV)?
Novus Acquisition & Development Stock: Key Questions Answered
These answers are editorial: 1 of these 1 answer is drawn from the NDEV research dossier (written Mar 17, 2026 by gemini-2.0-flash). Figures in this section are not part of the source register.
What are the main risks for NDEV?
The main risks for Novus Acquisition & Development Corp. include regulatory changes in the cannabis industry, which could impact the legality and marketability of its insurance products.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources — records for every figure on this page (14 figures)
The 14 rows below are exactly the facts the evidence-backed sections of this page printed — the 10-second verdict, the MoonshotScore, price and market value, the five questions with their receipts, and the records behind this page. Known dates and sources are recorded on their own rows; an em dash or UNRECORDED tier preserves a stored observation without inventing either. The quarterly income statement is provider-standardized (FMP) under one row, and scale definitions — a 0-100 rating, the band ladder, the Piotroski 0–9 range — are fixed rather than measured. No number in those sections was generated by a model. The register does not cover quoted third-party headlines, the dated council readings, or the Frequently Asked Questions; each of those says where it came from where it stands.
"As of" is the date the value is true for where the source carries one — a quarter end, a filing date, a price close, the day the score was computed. A cached observation with no source date remains undated; the page publication date is not used as a substitute.
FMP — 9 facts from Financial Modeling Prep endpoint families
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
px.last | Latest provided price | $0.0131 | FMP | Financial Modeling Prep (FMP) · quote — Dated to the US trading session the price belongs to, derived from the quote record's timestamp (weekend and pre-open reads roll back to the previous weekday; exchange holidays are not modelled). The record does not establish an exchange execution time. Retrieved 2026-10-05T13:45:07.531Z. | |
px.change | Change on the day | 0.00% | FMP | Financial Modeling Prep (FMP) · quote | |
px.mcap | Market capitalisation | $1.39M | FMP | Financial Modeling Prep (FMP) · quote — Date unknown Market cap record date: 2026-10-02. FMP quote timestamp: 2026-10-02T20:00:00.000Z. Captured from FMP at 2026-10-05T13:45:06.407Z. No share-count basis is inferred; this page preserves the reported amount instead of recalculating it from shares. | |
px.change_abs | Change on the day, in dollars | $0.00 | FMP | Financial Modeling Prep (FMP) · quote | |
px.pe | Price / earnings (trailing) | 11.91 | FMP | Financial Modeling Prep (FMP) · quote | |
px.volume | Shares traded on the day | 625 | FMP | Financial Modeling Prep (FMP) · quote | |
fin.q_revenue | Revenue, Q2 FY2026 | $107,785 | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
fin.q_income | Net income, Q2 FY2026 | $50,838 | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
fin.q_table | Quarterly income statement | 4 quarters through Q2 FY2026 | FMP | Financial Modeling Prep (FMP) · income statement (quarterly), as filed |
UNRECORDED — 5 facts from stored observations whose source was not recorded
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
px.range52 | 52-week range | $0.0028 – $0.0327 | UNRECORDED | Stored company-profile observation — Captured 2026-10-04 | |
id.employees | Employees | 1 | UNRECORDED | Stored company-profile observation — Captured 2026-10-04 | |
id.ceo | Chief executive | Gary Frank Labrozzi | UNRECORDED | Stored company-profile observation — Captured 2026-10-04 | |
fin.scores | Distress and quality screens | Altman Z 0.56 · Piotroski F 4 | UNRECORDED | Stored financial-scores observation — Captured 2026-10-03 · Expired observation | |
fin.ratios | Return and yield ratios (trailing twelve months) | ROE 10.4% · ROA 10.0% · current ratio 1.43 · earnings yield 9.8% | — | UNRECORDED | Stored key metrics — Date unknown |
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
Data provided for informational purposes only.